Atlas Arteria stock
Price history
−24.95% over the period1 year: from $5.01 (November 20, 2025) to $3.76 (November 20, 2026), −24.95%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 20, 2026 | $3.76 |
| October 30, 2026 | $3.71 |
| September 30, 2026 | $3.95 |
| August 31, 2026 | $4.59 |
| July 31, 2026 | $5.03 |
| June 30, 2026 | $5.10 |
| May 29, 2026 | $4.93 |
| April 30, 2026 | $4.80 |
| March 31, 2026 | $4.28 |
| February 27, 2026 | $4.80 |
| January 30, 2026 | $4.97 |
| December 31, 2025 | $4.88 |
| November 28, 2025 | $4.98 |
| November 20, 2025 | $5.01 |
At a glance
The company
Owns and operates toll roads and tunnels across France, Germany, Australia, Bermuda and the United States
Latest results
Quarter to June 30, 2026 · EPS $0.08
TickerLandia's take on Atlas Arteria
- Cheaper than usual relative to earnings: P/E on the latest fiscal year 21 vs a median of 27 over its last 9 fiscal years.
- Pricier than similar companies: trailing 12-month P/E 47 vs 15 (+223%) in a group of 10.
- Strong point: Dividend (82/100 in its group). Weak point: Financial strength (22/100).
- “Dividend traps” (Australia): No. 2 of 14.
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−28.18% from the 52-week high
Analysts · 10 analysts
Average target$3.93+4.64% vs. price
Buy 2 · Hold 4 · Sell 4
TickerLandia Fingerprint: Atlas Arteria
Compared with similar companies: very high dividend.
Financials and price compared with 10 companies in the infrastructure operations industry, worldwide. Momentum and risk compared with 1,074 Asia-Pacific stocks.
Pricehigh76
How much it costs relative to what it produces.
Metric Value Position in group Price/sales 34.9 95 P/E (trailing 12 months) 47.0 85 Forward P/E 15.0 81 EV/EBITDA 229.4 95 Price/book 1.05 25 Profitabilitylow33
How much it earns on revenue and capital.
Metric Value Position in group Gross margin 48.2% 45 Operating margin −24.6% 5 Net marginabove 100%: likely one-off items 171.4% 95 ROE 0.6% 15 ROA −0.3% 5 Earnings stabilitylow35
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 8.8% 15 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 55 Growthaverage48
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) +10.62% 45 Revenue growth (year over year) −4.10% 25 Earnings growth (year over year) +8.10% 75 Financial strengthlow22
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Net debt/EBITDAcounts in reverse: lower means more financial strength 29.2 6 Debt/equitycounts in reverse: lower means more financial strength 0.31 72 Interest coverage −0.23 5 Current ratio 0.75 5 Dividendvery high82
How much it returns to shareholders, and for how long.
Metric Value Position in group Dividend yield 10.6% 94 Consecutive dividend years 14 years 72 Payout ratiopays out more than its earnings 513.0% 81 Market momentumweak22
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) −17.87% 20 Relative strength (6 months) −22.70% 19 1-year return −24.95% 17 Distance from 200-day average −17.51% 34 Risklow33
How much the price swings.
Metric Value Position in group Volatility (60 days) 29.1% 30 Maximum drawdown (12 months) 28.5% 37 Beta (1 year) 0.48 32
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Atlas Arteria is cheaper than in the past and pricier than similar companies
On the latest fiscal year's earnings (2025), Atlas Arteria's P/E today is 21.0, below the median of its last 9 fiscal years (26.9; between 7.42 and 299.9 from 2016 to 2025). Atlas Arteria's P/E (trailing 12 months): 47.0, +223% against the median of a group of 10 similar companies (14.6).
Compared with 10 similar companies
| Metric | Atlas Arteria | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 47.0 | High | |
| Forward P/E | 15.0 | High | |
| Operating margin | -24.6% | Low | |
| ROE | 0.6% | Low | |
| Debt/equity | 0.31 | Middle |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Atlas Arteria. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
$74.3M
Latest quarter · Q2 2026
Net income
$116.4M
Latest quarter · Q2 2026
Quarterly net margin
156.7%
Latest quarter · Q2 2026
Numbers and valuation
Full valuation- Market cap
- $5.47B
- P/E
- 47.0
- EPS
- $0.08
- Volume
- 772.11K
- Daily trading
- €2.84M
- Dividend yield
- 10.64%
- Last ex-dividend on September 23, 2026
How Atlas Arteria is changing
All resultsRevenue grew 8.5% a year on average over the last 5 years
Operating margin rose from −17.6% to −13.9%
Less cash than profit: free cash flow equal to 29% of net income
Returns
Atlas Arteria returns with dividends
$1,000 invested in Atlas Arteria 5 years ago, on November 22, 2021, would be worth $886 today with dividends reinvested: −11.35% in total, −2.38% per year. On price alone it would be $605 (−39.49%).
| Period | Atlas Arteria | S&P/ASX 200 | $1,000 becomes |
|---|---|---|---|
| 1 month | +2.17% | −2.54% | $1,022 |
| 6 months | −21.83% | +1.13% | $782 |
| Year to date | −22.95% | −1.40% | $770 |
| 1 year | −17.70% | +0.47% | $823 |
| 3 years | −16.96% | +21.74% | $830 |
| 5 years | −11.35% | +16.86% | $886 |
| 10 years | +74.03% | +60.57% | $1,740 |
Over the last 6 months it has done better than 19% of the stocks in the Industrials sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. S&P/ASX 200: price only. Calculate your investment
The chart in detail
Atlas Arteria: technical analysis
Atlas Arteria is in a downtrend: the price is below its 50- and 200-session moving averages, and the 200-session average is falling. The price is 52.7% below its all-time closing high ($7.94, February 19, 2020).
- Trend
- Downward
- RSI (14 sessions)
- 44
- Between 30 and 70
- vs 200-session average
- −17.51%
Support and resistance
Price areas where Atlas Arteria has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance$4.75+26.44%5 touches, last on May 20, 2026
- Resistance$4.36+15.96%2 touches, last on April 8, 2026
- Resistance$4.21+11.84%2 touches, last on April 21, 2026
- Last price$3.76
- No support below: the price is near the lows of the year
Volatility and risk
Over the last year it has moved less than the S&P/ASX 200.
- Beta (1 year) vs S&P/ASX 200
- 0.48
- Volatility (60 sessions, annualised)
- 29.1%
- Largest fall in the last year
- −28.52%
Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Atlas Arteria: seasonality
Average monthly price change over 17 years
Over the last 17 years, the strongest month for Atlas Arteria has been April: +3.90% on average, positive in 13 years out of 17. The weakest has been September: −4.40% on average, positive in 4 years out of 17. November, the current month, has been positive in 10 years out of 16 (+2.63% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +1.06% | +2.19% | 9 of 16 |
| February | +0.87% | −0.29% | 6 of 17 |
| March | −0.74% | +0.77% | 9 of 17 |
| April | +3.90% | +4.26% | 13 of 17 |
| May | +1.96% | +2.71% | 13 of 17 |
| June | +1.05% | −1.15% | 6 of 17 |
| July | +2.98% | +1.38% | 10 of 17 |
| August | +1.46% | +2.16% | 9 of 17 |
| September | −4.40% | −6.62% | 4 of 17 |
| October | +0.77% | −0.20% | 8 of 17 |
| November | +2.63% | +2.49% | 10 of 16 |
| December | +0.73% | −0.01% | 8 of 16 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Atlas Arteria and its competitors
Revenue of AUD 160 million in the fiscal year ended December 2025 rose 9.7% from the previous year, a result of toll road assets that Atlas Arteria Limited owns, develops and operates. Its largest holdings are in France, where it holds stakes of between 30.79% and 30.85% in the APRR motorway network, the ADELAC commuter road and the A79 transversal link. In Germany it owns 100% of the Warnow Tunnel in Rostock, and in the United States it holds 66.67% of the Chicago Skyway in Chicago and 100% of the Dulles Greenway in Virginia.
- Headquarters
- Melbourne, Australia
- Founded
- 2009
- Chief executive
- Hugh Wehby
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Atlas ArteriaALX | $3.64B | -24.6% | 47.0 | −21.83% |
| Ventia Services GroupVNT | $2.5B | 7.2% | 14.4 | −22.95% |
| Transurban GroupTCL | $30.58B | 30.0% | 122.5 | +2.87% |
| Motiva Infraestrutura de MobilidadeMOTV3 | $5.35B | 33.5% | 8.61 | +9.10% |
| Promotora y Operadora de InfraestructuraPINFRA | $6.11B | 51.8% | 13.2 | +8.98% |
| Impulsora del Desarrollo y el Empleo en America Latina SABIDEAL/B-1 | $6.45B | 58.1% | 15.6 | 0.00% |
Same industry or related industries, similar size. Compare Atlas Arteria with its competitors · Full profile
